Each of the 6 significant variables (older age ≥75 years, female sex, malignancy, CKD stage ≥ 3, low preoperative Hb < 12 g/dL, and ASA 3) identified from the comparison analysis was given a point score for the creation of the perioperative ABT prediction model. This evidence concerns the gene GSTM1 and chronic kidney disease.